Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

What's Keeping Korea From Becoming A Digital Healthcare Power?

Executive Summary

While digital healthcare start-ups are increasingly being established in South Korea, strict regulations and a limited market environment are keeping them from adopting innovative ideas and technologies to rapidly catch up with global competitors. A recent report on digital healthcare suggests what issues need to be resolved to improve the situation.

You may also be interested in...



AI-Driven Drug Development Seen Blossoming In Korea As Govt Lends Support

Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.

AI Healthcare, Medical Devices Shine In Korea Q1 Financings

After the financing draught suffered by Korean bioventures in 2023, it now seems the VC market is poised for a recovery as investors shift attention again to the healthcare sector, with a spotlight on AI-based solutions and device firms.

Window Of Opportunity: Korea Unveils Cutting-Edge Bio Initiative

South Korea is moving forward with plan to set up a Boston-type biotech cluster in Osong as part of a broader initiative unveiled by President Yoon, while the biopharma industry is calling for rapid process, exceptional support.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC124257

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel